Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
13F holders, Q1 2024 (March 31)6holders
$1.55avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) in their 13F filings. The largest holders were Ofi Invest Asset Management ($9.0M), New York State Common Retirement Fund ($6.1M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($5.6M).
- Company
- Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
- CUSIP
- 803607AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $9.0M |
| Exits | 1 | $2.5M |
Ownership 6 holders
| Ofi Invest Asset Management | 0.24% | Add +121233.3% | 4,004,000 | $9.0M |
| New York State Common Retirement Fund | 0.01% | Reduce -37.5% | 5,251,000 | $6.1M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | New | 4,850,000 | $5.6M |
| Loomis Sayles & Co. L P | 0.00% | New | 14,454 | $1.9M |
| Lord, Abbett & Co. LLC | 0.00% | New | 1,252,000 | $1.5M |
| Bank of New York Mellon Corp | 0.00% | No change | 900,000 | $1.1M |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) the manager owns.